top of page
Profile
Join date: Oct 31, 2022
Posts (5)
Mar 6, 2025 ∙ 1 min
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Evaluate the efficacy and safety of targeted therapies in VEXAS syndrome.
2
0
Sep 23, 2024 ∙ 4 min
A rare cause of AA amyloidosis: Hereditary epidermolysis bullosa
First author : Chaabouni et al Review: Néphrologie et thérapeutique Reference : DOI : 10.1016/j.nephro.2021.08.005 Link to article:...
1
0
Jul 14, 2024 ∙ 1 min
Diagnosis traps for patients with acquired NLRP3 mutation (CAPS)
L’article met en lumière les défis diagnostiques des syndromes périodiques associés à la cryopyrine (CAPS).
0
0
CEREMAIA
Admin
More actions
bottom of page